• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

ChemoCentryx

Biotech

AdComm experts split on whether to OK ChemoCentryx's avacopan

Ten experts voted that the benefit-risk profile supports approval, while the other eight voted against authorizing the rare disease drug.
Nick Paul Taylor May 7, 2021 6:47am

ChemoCentryx's stock sinks as FDA flags issues with pivotal data

May 5, 2021 8:25am

ChemoCentryx pulls conditional approval filing

Jan 24, 2019 9:40am

ChemoCentryx eyes combinations after posting pancreatic cancer OS data 

Jan 23, 2018 8:05am

Vifor flies solo, plans spending spree as sister unit files IPO

Apr 7, 2017 2:38am

$85M windfall for PhIII licensing deal sparks a rally for ChemoCentryx

May 11, 2016 7:39am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
  • ©2022 Questex LLC All rights reserved.
  • Terms of use
  • Privacy Policy